A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth
about
Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyElimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression.Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies.CD8(+) T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysisFas expression by tumor stroma is required for cancer eradication.Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumoursEnrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter.Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response.Inferring the Impact of Regulatory Mechanisms that Underpin CD8+ T Cell Control of B16 Tumor Growth In vivo Using Mechanistic Models and Simulation.Spleen cells from young but not old immunized mice eradicate large established cancers.Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model.Complete remission of cancer in late-stage disease by radiation and transfer of allogeneic MHC-matched immune T cells: lessons from GvL studies in animals.Targeting cancer-specific mutations by T cell receptor gene therapy.The importance of the tumor microenvironment in the therapeutic management of cancer.MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancer.Rejuvenated T cells attack old tumorsEradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.DNA vaccines for prostate cancer.CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
P2860
Q28084489-B311D4EB-1040-48D5-968A-62DC71112CB5Q33587034-501792B9-BD73-4961-8736-88C3043DE9A5Q33854515-96C85CCE-8481-41B3-9A28-4DA7955B0361Q35107009-0E11CE03-7DEC-40D4-8732-C656A2BD332EQ35655089-584DD19C-5B20-4221-B6C8-4AEB704EA7E1Q36598412-FA218FC5-E789-435D-8928-840FC2EEEF05Q36638606-086F4686-1C6B-4092-8AD2-B8666E7EDA38Q37370230-FBE4CCEB-7986-4FEE-B2D6-BF39EA5A48BBQ37492464-B9B861BA-DC57-49C0-BE99-CF9E0F1B234EQ37529144-A949EA8C-7F73-4652-A21A-9592A853CFAEQ37542092-314B82F2-E827-4116-ABFF-B1CB376FB12CQ37554202-5A237C3C-972A-4CEC-BA87-D1DAA87DCA05Q37706396-2DCA9D14-5631-4C39-81AA-546A84451246Q37718304-C65CC751-D3E6-42CA-9AB8-C53A8CE21372Q38194489-B45EF4F6-E869-4202-9A66-8AE1B986976EQ38366556-DE552C1F-D5C6-4A2A-98BD-CCF877AD70F7Q38534294-FF05F9AC-B107-4FEA-B72B-9BE3CC5E51FDQ39290133-FA3218B0-1C19-4694-AE4E-358084D00D2CQ39546521-13F265E6-9099-4492-8FF8-E7B5809895BAQ42072059-D7CA3BF2-1389-4216-9EF3-03DC8D0DD1E0Q42097613-1D689B37-AF5E-43D5-8467-6DF12C3A33D8Q42573824-B6D1386C-7237-42EC-9DFB-CC25D9D231D7Q51142505-F60504B0-1C79-4394-905D-C0AE55697706Q58565339-F88D02C7-7D1A-4781-9661-51CA9861D6F8
P2860
A systematic analysis of experimental immunotherapies on tumors differing in size and duration of growth
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A systematic analysis of exper ...... in size and duration of growth
@ast
A systematic analysis of exper ...... in size and duration of growth
@en
type
label
A systematic analysis of exper ...... in size and duration of growth
@ast
A systematic analysis of exper ...... in size and duration of growth
@en
prefLabel
A systematic analysis of exper ...... in size and duration of growth
@ast
A systematic analysis of exper ...... in size and duration of growth
@en
P2093
P2860
P356
P1433
P1476
A systematic analysis of exper ...... in size and duration of growth
@en
P2093
Donald A Rowley
Hans Schreiber
Ronald A Thisted
P2860
P304
P356
10.4161/ONCI.1.2.18311
P50
P577
2012-03-01T00:00:00Z